Indivior PLC Indivior to Participate in Upcoming Conferences (6604A)
May 25 2023 - 9:30AM
UK Regulatory
TIDMINDV
RNS Number : 6604A
Indivior PLC
25 May 2023
Indivior To Participate In Upcoming Investor Conferences
Slough, UK, and Richmond, VA, May 25, 2023 - Indivior PLC (LSE:
INDV) today announced that it will participate in the following
investor events:
-- Jefferies Healthcare Conference - New York City, June 7(th)
Mark Crossley, Chief Executive Officer (CEO) and Ryan Preblick,
Chief Financial Officer (CFO), will host 1x1/group meetings on
Wednesday, June 7(th) and host a presentation Wednesday June 7(th)
at 3:00 p.m. US EST. Investors can contact their Jefferies
representative to schedule a meeting. The presentation will be
available at www.indivior.com and can also be viewed using the
following webcast link:
https://wsw.com/webcast/jeff281/indv.l/2074930
-- Stifel European Healthcare Summit - Bordeaux, France, June 29(th) and 30(th)
Mark Crossley, CEO, will participate in the Stifel European
Healthcare Conference in Bordeaux, France. Mr. Crossley will host
1x1/group meetings on Thursday, June 29(th) and Friday, June 30(th)
. Investors can contact their Stifel representative to schedule a
meeting.
About Indivior
Indivior is a global pharmaceutical company working to help
change patients' lives by developing medicines to
treat substance use disorders (SUD) and serious mental
illnesses. Our vision is that all patients around the world
will have access to evidence-based treatment for the chronic
conditions and co-occurring disorders of SUD. Indivior is dedicated
to transforming SUD from a global human crisis to a recognized and
treated chronic disease. Building on its global portfolio of OUD
treatments, Indivior has a pipeline of product candidates designed
to both expand on its heritage in this category and potentially
address other chronic conditions and co-occurring disorders of SUD,
including alcohol use disorder and cannabis use disorder.
Headquartered in the United States in Richmond, VA, Indivior
employs more than 1,000 individuals globally and its portfolio of
products is available in 39 countries worldwide. Visit
www.indivior.com to learn more. Connect with Indivior on LinkedIn
by visiting www.linkedin.com/company/indivior.
Contact:
Jason Thompson
Vice President, Investor Relations
Tel: 804-402-7123 or jason.thompson@indivior.com
Tim Owens
Director, Investor Relations
Tel: 804-263-3978 or timothy.owens@indivior.com
###
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCEANSSAENDEEA
(END) Dow Jones Newswires
May 25, 2023 09:30 ET (13:30 GMT)
Indivior (LSE:INDV)
Historical Stock Chart
From Apr 2024 to May 2024
Indivior (LSE:INDV)
Historical Stock Chart
From May 2023 to May 2024